Clinical Trials Update: Dec. 6, 201012/06/10
(HealthDay News) -- Here are the latest clinical trials,
This study is for people aged 12 to 45 with moderate-to-severe
facial acne. Participants may qualify for compensation up to
The research site is in Bryan, Texas.
This study will evaluate kd-247, a humanized monoclonal
antibody, in people with HIV-1 infection who lack symptoms and are
not receiving current antiretroviral therapy.
The research site is in Tamarac, Fla.
This study will compare different FDA-approved treatment options
for acute migraines.
The research site is in Charleston, S.C.
ClinicalConnection.com. All rights reserved.
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.